Mirum Pharmaceuticals

MIRM

NASDAQHealth Care

Income Statement

Total Revenue$336.89M

Gross Profit$255.25M

Operating Income$-87.61M

EBITDA$-47.38M

EBIT$-72.6M

Pre-tax Income$-21.43M

Net Income$-87.94M

Cash Equivalent$245.67M

Total Debt$314.45M

Book Value$230.31M

Book Value Per Share4.85

Return on Equity (ROE)-38.97%

Return on Assets (ROA)-13.11%

Return on Invested Capital (ROI)-16.48%

Net Profit Margin-26.10%

Current Ratio3.10

Quick Ratio2.83

Long-Term Debt / Equity1.37